Investigational drugs for nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Investigational drugs for nasopharyngeal carcinoma

Published:2017-05-08 Issue:6 Volume:26 Page:677-685
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Ma Brigette B.Y.¹²³,Hui Edwin P¹²³,Chan Anthony T.C.¹²³

Affiliation:

1. State Key Laboratory in Oncology in South China, Sir YK Pao Centre for Cancer, Hong Kong SAR, China

2. Department of Clinical Oncology, Hong Kong Cancer Institute, Hong Kong SAR, China

3. Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2017.1324568

Reference81 articles.

1. Global cancer statistics, 2012

2. Cancer statistics in China, 2015

3. Hong Kong Cancer Registry, Hong Kong Hospital Authority. 2016. Available from: http://www3.ha.org.hk/cancereg/

4. Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective

5. Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomal miR-18a-5p promotes EMT and metastasis of NPC cells via targeting BTG3 and activating the Wnt/β-catenin signaling pathway;Cell Cycle;2023-06-07

2. Regorafenib inhibits growth, survival and angiogenesis in nasopharyngeal carcinoma and is synergistic with Mcl-1 inhibitor;Journal of Pharmacy and Pharmacology;2023-05-03

3. MicroRNA-372 acts as a double-edged sword in human cancers;Heliyon;2023-05

4. Molecular Signaling Pathways in Nasopharyngeal Carcinoma;Medical Radiology;2023

5. Oncogenic viruses as etiological risk factors for head and neck cancers: An overview on prevalence, mechanism of infection and clinical relevance;Archives of Oral Biology;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3